Close Menu

An international team led by investigators at Emory University explore human host B cell responses over time in Ebola virus (EBOV) infection survivors. Using ELISA and viral plaque reduction assays, the researchers profiled antibodies developed against an EBOV surface glycoprotein in blood samples from four Ebola individuals who survived a West African outbreak that started in 2014.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.